Plotted Points Statistics |
11-KETOTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 92% | 16% | 92% | 15% |
Total | 34 | 92% | 16% | 92% | 15% |
Sample Statistics |
11-KETOTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 89% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 39 | . | |
False Negatives | 3 | 8% | 3 out of 38 |
Not Spiked | 92 | . | |
False Positives | 0 | 0% | 0 out of 91 |
Plotted Points Statistics |
17-ALPHA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 72 | 89% | 25% | 88% | 13% |
Total | 72 | 89% | 25% | 88% | 13% |
Sample Statistics |
17-ALPHA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 72 | 91% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 3 | 4% | Spiked |
Spiked | 80 | . | |
False Negatives | 4 | 5% | 4 out of 79 |
Not Spiked | 51 | . | |
False Positives | 1 | 2% | 1 out of 50 |
BQS OBSP Determination: |
17-ALPHA-ETHYNYLESTRADIOL |
METHOD: 4434 , TESTIDCODE: 64529GM005 |
Open Data Set |
Plotted Points Statistics |
17-ALPHA-ETHYNYLESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 64 | 81% | 16% | 80% | 13% |
Total | 64 | 81% | 16% | 80% | 13% |
Sample Statistics |
17-ALPHA-ETHYNYLESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 64 | 80% | Spiked |
Estimated Values | 1 | 1% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 81 | . | |
False Negatives | 16 | 20% | 16 out of 80 |
Not Spiked | 50 | . | |
False Positives | 2 | 4% | 2 out of 49 |
Plotted Points Statistics |
17-BETA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 69 | 85% | 17% | 83% | 12% |
Total | 69 | 85% | 17% | 83% | 12% |
Sample Statistics |
17-BETA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 69 | 86% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 82 | . | |
False Negatives | 10 | 13% | 10 out of 80 |
Not Spiked | 49 | . | |
False Positives | 0 | 0% | 0 out of 49 |
Plotted Points Statistics |
3-BETA-COPROSTANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 60 | 82% | 27% | 78% | 28% |
Total | 60 | 82% | 27% | 78% | 28% |
Sample Statistics |
3-BETA-COPROSTANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 60 | 77% | Spiked |
Estimated Values | 3 | 4% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 80 | . | |
False Negatives | 18 | 23% | 18 out of 78 |
Not Spiked | 51 | . | |
False Positives | 0 | 0% | 0 out of 50 |
Plotted Points Statistics |
4,4BISPHENOL F |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 19 | 100% | 29% | 88% | 30% |
Total | 19 | 100% | 29% | 88% | 30% |
Sample Statistics |
4,4BISPHENOL F |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 19 | 100% | Spiked |
Estimated Values | 19 | 100% | Spiked |
Deleted Values | 1 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 20 | . | |
False Negatives | 0 | 0% | 0 out of 19 |
Not Spiked | 27 | . | |
False Positives | 0 | 0% | 0 out of 27 |
Sample Statistics |
4,4BISPHENOL S |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 0 | . | Spiked |
Estimated Values | 0 | . | Spiked |
Deleted Values | 2 | 100% | Spiked + Not Spiked |
Spiked, Censored | 0 | . | Spiked |
Spiked | 0 | . | |
False Negatives | 0 | . | 0 out of 0 |
Not Spiked | 2 | . | |
False Positives | 0 | . | 0 out of 0 |
Plotted Points Statistics |
4-ANDROSTENE-3,17-DIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 35 | 69% | 19% | 70% | 19% |
Total | 35 | 69% | 19% | 70% | 19% |
Sample Statistics |
4-ANDROSTENE-3,17-DIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 80% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 3 | 7% | Spiked |
Spiked | 46 | . | |
False Negatives | 6 | 14% | 6 out of 44 |
Not Spiked | 85 | . | |
False Positives | 1 | 1% | 1 out of 85 |
Plotted Points Statistics |
BISPHENOL A |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 71 | 77% | 21% | 73% | 22% |
Total | 71 | 77% | 21% | 73% | 22% |
Sample Statistics |
BISPHENOL A |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 71 | 99% | Spiked |
Estimated Values | 36 | 50% | Spiked |
Deleted Values | 4 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 75 | . | |
False Negatives | 1 | 1% | 1 out of 72 |
Not Spiked | 56 | . | |
False Positives | 0 | 0% | 0 out of 55 |
Plotted Points Statistics |
CHOLESTEROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 67 | 87% | 21% | 83% | 19% |
Total | 67 | 87% | 21% | 83% | 19% |
Sample Statistics |
CHOLESTEROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 67 | 87% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 80 | . | |
False Negatives | 10 | 13% | 10 out of 77 |
Not Spiked | 51 | . | |
False Positives | 2 | 4% | 2 out of 51 |
Plotted Points Statistics |
CIS-ANDROSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 72% | . | 72% | 0% |
>= Reporting Level | 50 | 76% | 17% | 77% | 18% |
Total | 51 | 76% | 17% | 76% | 18% |
Sample Statistics |
CIS-ANDROSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 51 | 78% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 5 | 8% | Spiked |
Spiked | 65 | . | |
False Negatives | 9 | 14% | 9 out of 65 |
Not Spiked | 66 | . | |
False Positives | 1 | 2% | 1 out of 64 |
Plotted Points Statistics |
DIHYDROTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 72% | 18% | 73% | 15% |
Total | 40 | 72% | 18% | 73% | 15% |
Sample Statistics |
DIHYDROTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 82% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 50 | . | |
False Negatives | 8 | 16% | 8 out of 49 |
Not Spiked | 81 | . | |
False Positives | 1 | 1% | 1 out of 80 |
Plotted Points Statistics |
EPITESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 65 | 73% | 17% | 72% | 13% |
Total | 65 | 73% | 17% | 72% | 13% |
Sample Statistics |
EPITESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 65 | 96% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 70 | . | |
False Negatives | 3 | 4% | 3 out of 68 |
Not Spiked | 61 | . | |
False Positives | 0 | 0% | 0 out of 61 |
Plotted Points Statistics |
EQUILENIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 36 | 91% | 36% | 89% | 42% |
Total | 36 | 91% | 36% | 89% | 42% |
Sample Statistics |
EQUILENIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 36 | 84% | Spiked |
Estimated Values | 3 | 7% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 7 | 16% | 7 out of 43 |
Not Spiked | 43 | . | |
False Positives | 8 | 19% | 8 out of 42 |
Plotted Points Statistics |
EQUILIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 71% | 18% | 64% | 1% |
>= Reporting Level | 61 | 68% | 18% | 65% | 16% |
Total | 66 | 69% | 18% | 65% | 14% |
Sample Statistics |
EQUILIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 66 | 85% | Spiked |
Estimated Values | 66 | 85% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 79 | . | |
False Negatives | 11 | 14% | 11 out of 78 |
Not Spiked | 52 | . | |
False Positives | 0 | 0% | 0 out of 51 |
Plotted Points Statistics |
ESTRIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 72 | 82% | 16% | 81% | 15% |
Total | 72 | 82% | 16% | 81% | 15% |
Sample Statistics |
ESTRIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 72 | 92% | Spiked |
Estimated Values | 1 | 1% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 80 | . | |
False Negatives | 5 | 6% | 5 out of 78 |
Not Spiked | 51 | . | |
False Positives | 0 | 0% | 0 out of 51 |
Plotted Points Statistics |
ESTRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 66 | 75% | 16% | 74% | 11% |
Total | 66 | 75% | 16% | 74% | 11% |
Sample Statistics |
ESTRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 66 | 80% | Spiked |
Estimated Values | 5 | 6% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 5 | 6% | Spiked |
Spiked | 83 | . | |
False Negatives | 11 | 13% | 11 out of 82 |
Not Spiked | 48 | . | |
False Positives | 0 | 0% | 0 out of 46 |
Plotted Points Statistics |
MESTRANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 50 | 49% | 14% | 48% | 12% |
Total | 50 | 49% | 14% | 48% | 12% |
Sample Statistics |
MESTRANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 50 | 63% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 2 | 3% | Spiked |
Spiked | 81 | . | |
False Negatives | 28 | 35% | 28 out of 80 |
Not Spiked | 50 | . | |
False Positives | 2 | 4% | 2 out of 49 |
Plotted Points Statistics |
NORETHINDRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 58 | 79% | 18% | 75% | 16% |
Total | 58 | 79% | 18% | 75% | 16% |
Sample Statistics |
NORETHINDRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 73% | Spiked |
Estimated Values | 1 | 1% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 3 | 4% | Spiked |
Spiked | 80 | . | |
False Negatives | 18 | 23% | 18 out of 79 |
Not Spiked | 51 | . | |
False Positives | 0 | 0% | 0 out of 50 |
Plotted Points Statistics |
PROGESTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 69 | 45% | 15% | 42% | 12% |
Total | 69 | 45% | 15% | 42% | 12% |
Sample Statistics |
PROGESTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 69 | 87% | Spiked |
Estimated Values | 69 | 87% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 81 | . | |
False Negatives | 10 | 13% | 10 out of 79 |
Not Spiked | 50 | . | |
False Positives | 0 | 0% | 0 out of 50 |
Plotted Points Statistics |
TESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 55 | 77% | 13% | 77% | 10% |
Total | 55 | 77% | 13% | 77% | 10% |
Sample Statistics |
TESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 55 | 89% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 63 | . | |
False Negatives | 7 | 11% | 7 out of 62 |
Not Spiked | 68 | . | |
False Positives | 3 | 4% | 3 out of 67 |
BQS OBSP Determination: |
TRANS-DIETHYLSTILBESTROL |
METHOD: 4434 , TESTIDCODE: 64536GM005 |
Open Data Set |